Literature DB >> 24154999

Refractory postsurgical pyoderma gangrenosum in a patient with Beckwith Wiedemann syndrome: response to multimodal therapy.

Faiza Fakhar1, Sehrish Memon, Diane Deitz, Richard Abramowitz, Deborah R Alpert.   

Abstract

Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis that may be difficult to diagnose and treat. We presented a 41-year-old woman who required skin grafting following third-degree burns to her left breast. She suffered recurrent graft dehiscence and infections over many years, prompting elective bilateral reduction mammoplasty. She subsequently developed suture margin ulcerations unresponsive to topical therapies and antibiotics. Skin biopsies were non-specific, and a clinical diagnosis of PG was established. Although initially responsive to corticosteroids, wounds promptly recurred following steroid taper. She was treated unsuccessfully with various immunomodulatory agents and underwent elective bilateral mastectomy. Following a mastectomy, she developed progressive deep chest wall ulcerations. She failed numerous immunomodulatory treatments, surgical wound closure and negative pressure wound therapy. Ultimately, treatment with adalimumab, mycophenolate mofetil and prednisone, in addition to hyperbaric oxygen therapy facilitated progressive healing. Our case highlights the role of collaborative multimodal therapy for the treatment of refractory PG.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24154999      PMCID: PMC3822173          DOI: 10.1136/bcr-2013-201084

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  20 in total

1.  Managing pyoderma gangrenosum: a synergistic approach combining surgical débridement, vacuum-assisted closure, and hyperbaric oxygen therapy.

Authors:  Jeffrey A Niezgoda; E Bernadette Cabigas; Heidi K Allen; John P Simanonok; Eric P Kindwall; James Krumenauer
Journal:  Plast Reconstr Surg       Date:  2006-02       Impact factor: 4.730

Review 2.  Pyoderma gangrenosum: dermatologic application of hyperbaric oxygen therapy.

Authors:  William D Tutrone; Kim Green; Jeffrey M Weinberg; Selin Caglar; Dick Clarke
Journal:  J Drugs Dermatol       Date:  2007-12       Impact factor: 2.114

3.  Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.

Authors:  T N Brooklyn; M G S Dunnill; A Shetty; J J Bowden; J D L Williams; C E M Griffiths; A Forbes; R Greenwood; C S Probert
Journal:  Gut       Date:  2005-09-27       Impact factor: 23.059

Review 4.  Hyperbaric-oxygen therapy.

Authors:  P M Tibbles; J S Edelsberg
Journal:  N Engl J Med       Date:  1996-06-20       Impact factor: 91.245

5.  Systemic pyoderma gangrenosum responding to infliximab and adalimumab.

Authors:  V G Hubbard; A C Friedmann; P Goldsmith
Journal:  Br J Dermatol       Date:  2005-05       Impact factor: 9.302

6.  Gauze-based negative pressure wound therapy: a valid method to manage pyoderma gangrenosum.

Authors:  Marco Fraccalvieri; Maria Teresa Fierro; Marco Salomone; Paolo Fava; Enrico M Zingarelli; Giovanni Cavaliere; Maria G Bernengo; Stefano Bruschi
Journal:  Int Wound J       Date:  2012-08-14       Impact factor: 3.315

7.  Pyoderma gangrenosum of the breast: a diagnosis not to be missed.

Authors:  A Duval; N Boissel; J M Servant; C Santini; A Petit; M D Vignon-Pennamen
Journal:  J Plast Reconstr Aesthet Surg       Date:  2010-09-18       Impact factor: 2.740

Review 8.  Clinical management of pyoderma gangrenosum.

Authors:  Uwe Wollina
Journal:  Am J Clin Dermatol       Date:  2002       Impact factor: 7.403

Review 9.  Etiology and management of pyoderma gangrenosum: a comprehensive review.

Authors:  Iris Ahronowitz; Joanna Harp; Kanade Shinkai
Journal:  Am J Clin Dermatol       Date:  2012-06-01       Impact factor: 7.403

10.  Pyoderma gangrenosum--rebel without a cure?

Authors:  Sharon E Jacob; Robyn S Weisman; Francisco A Kerdel
Journal:  Int J Dermatol       Date:  2008-02       Impact factor: 2.736

View more
  3 in total

Review 1.  Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases.

Authors:  Klaus Eisendle; Tobias Thuile; Jenny Deluca; Maria Pichler
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-04-28       Impact factor: 4.730

2.  Hyperbaric oxygen therapy in a case of cervical abscess extending to anterior mediastinum, with isolation of Prevotella corporis.

Authors:  Francesco Ciodaro; Francesco Gazia; Bruno Galletti; Francesco Galletti
Journal:  BMJ Case Rep       Date:  2019-07-10

3.  Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: A semi-systematic review.

Authors:  Hakim Ben Abdallah; Karsten Fogh; Rikke Bech
Journal:  Int Wound J       Date:  2019-01-03       Impact factor: 3.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.